NCT05725382

Nociception Level-guided Remifentanil Dosing in Children During General Anesthesia

Name: Clinical Trial NCT05725382
Creator: Pia Jaeger, MD, PhD
Keywords: Surgical Procedure, Unspecified, The NOL monitor (Pain Monitoring Device monitor-PMD200™), device, clinical trial, Denmark

Can Nociception Level-guided Remifentanil Dosing Reduce Postoperative Pain in Children During General Anesthesia: A Blinded, Randomized Controlled Trial

Pia Jaeger, MD, PhD·ClinicalTrials.gov·device·Device trialNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Surgical Procedure, Unspecified
Drug/Device/Intervention: The NOL monitor (Pain Monitoring Device monitor-PMD200™)
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Pia Jaeger, MD, PhD
Funder: Rigshospitalet, Denmark
Location: Copenhagen,Copenhagen,Køge,Vejle, Denmark

Timeline & enrollment

Phase: N/A
Start date: Feb 06, 2023
End date: Nov 01, 2025
Enrollment: 264 participants

Primary outcome

First pain score assessed at the PACU

Summary

The investigators aim to investigate whether administration of a short-acting opioid (remifentanil) guided by a pain monitor (nociceptive level monitor) during anesthesia, can reduce pain in children after surgery.  The investigators hypothesize that pain monitor-guided administration of remifentanil can reduce pain postoperatively compared with standard care.

ICD-10 classifications

Surgical procedure, unspecifiedMedical procedure, unspecifiedOther surgical proceduresDuring unspecified surgical and medical careDuring unspecified surgical and medical care

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05725382
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05725382 through Pure Global AI's free database. This phase not specified trial is sponsored by Pia Jaeger, MD, PhD and is currently Not yet recruiting. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 264 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.